Wed 2 Dec 2009 | 17:35 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For NeurogesX, Inc.

NeurogesX, Inc. (NGSX.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Biotechnology · View NGSX on other exchanges

As of 4:00pm EST

8.41USD

Price Change

+0.30

Percent Change

+3.70%

Analyst Recommendations

Independent Research | Broker Research

Name	Age	Since	Current Position
Rinne, Susan	57	--	Vice President - Regulatory Affairs
Markels, Michael	43	2006	Vice President - Commercial Operations and Business Development
DiTonno, Anthony	60	--	President, Chief Executive Officer, Director
Bienaime, Jean-Jacques	55	2004	Director
Kurtz, Neil	58	2006	Director
Nelsen, Robert	45	2000	Director
Goodwin, Bradford	54	2009	Director
Orwin, John	--	2009	Director
Tobias, Jeffrey	54	2005	Chief Medical Officer
Ghiglieri, Stephen	47	2003	Chief Financial Officer

Find out more about NGSX.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.